Medicare Covers GLP-1 Weight-Loss Drugs Starting July 1: What to Know
Medicare beneficiaries can access GLP-1 weight-loss drugs for $50/month beginning July 1. Here's what older Americans must consider before signing up.
Big news if you're on Medicare: starting July 1, qualifying beneficiaries can finally access GLP-1 weight-loss drugs — think Ozempic-class medications — through the program for the first time ever. The cost? Just $50 a month. That's a massive shift from the out-of-pocket sticker shock most people have faced trying to get these drugs without coverage.
Before you call your doctor, know this isn't a free pass for everyone. You have to qualify. Medicare isn't handing out GLP-1 scripts to every enrollee who asks — there are eligibility requirements tied to your health profile. Do your homework and have a real conversation with your physician about whether you meet the criteria.
Read more Why Maxing Your 401(k) Right Now May Be a Mistake →
Here's the part nobody talks about enough: side effects are real, and so is muscle loss. GLP-1 drugs are powerful. They can trigger nausea, digestive issues, and — critically for older adults — significant muscle mass reduction alongside the fat loss. Losing muscle in your 60s or 70s isn't just a cosmetic issue. It directly affects your mobility, balance, and long-term independence. That's not a reason to skip the drug, but it is a reason to pair it with resistance training and proper protein intake if you go this route.
For traders watching the healthcare and pharma space, this Medicare expansion is a demand catalyst worth tracking. Broader coverage for a massive, price-sensitive demographic could accelerate prescription volumes for GLP-1 manufacturers. Watch how utilization data shapes up in Q3 earnings calls across the sector.
Bottom line: $50 a month for a drug that's been running hundreds out-of-pocket is a genuine game-changer for Medicare enrollees. Just go in with eyes open about what these drugs actually do to your body. Continue reading at MarketWatch.com
